<?xml version="1.0" encoding="UTF-8"?>
<p>After oral administration, blood concentrations of ginsenosides are high, but their absorption rate is low. Both the absorption profile of ginsenosides in the intestinal mucosa and the availability of intact ginsenosides and their metabolites from the intestines are exceptionally low.
 <xref rid="med21743-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="med21743-bib-0611" ref-type="ref">
  <sup>611</sup>
 </xref> The maximal concentration of ginsenosides in plasma is reached within 2 h, suggesting that they are rapidly absorbed and distributed in tissues. Rg1, Re, Rb1, and Rc reach the brain, but their concentrations decline rapidly over time.
 <xref rid="med21743-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="med21743-bib-0617" ref-type="ref">
  <sup>617</sup>
 </xref> Rg1 and Re are more readily distributed in the brain, and they are considered the main components directly affecting the neurons of the CNS.
 <xref rid="med21743-bib-0617" ref-type="ref">
  <sup>617</sup>
 </xref> The plasma level of ginsenosides indicates that protopanaxadiol ginsenosides have higher concentrations and longer half‐lives than protopanaxatriol ginsenosides.
 <xref rid="med21743-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="med21743-bib-0617" ref-type="ref">
  <sup>617</sup>
 </xref> After the biotransformation of ginsenosides, the microbiota in the gut produces deglycosylated products.
 <xref rid="med21743-bib-0358" ref-type="ref">
  <sup>358</sup>
 </xref>, 
 <xref rid="med21743-bib-0618" ref-type="ref">
  <sup>618</sup>
 </xref>, 
 <xref rid="med21743-bib-0619" ref-type="ref">
  <sup>619</sup>
 </xref>, 
 <xref rid="med21743-bib-0620" ref-type="ref">
  <sup>620</sup>
 </xref> The intestinal bacteria isolated from human feces and some food‐derived microorganisms as well as fungi from soil around ginseng roots convert glycosylated ginsenosides to compound K,
 <xref rid="med21743-bib-0612" ref-type="ref">
  <sup>612</sup>
 </xref>, 
 <xref rid="med21743-bib-0620" ref-type="ref">
  <sup>620</sup>
 </xref>, 
 <xref rid="med21743-bib-0621" ref-type="ref">
  <sup>621</sup>
 </xref> which has great potential for cancer chemoprevention.
 <xref rid="med21743-bib-0342" ref-type="ref">
  <sup>342</sup>
 </xref> Compound K was the only ginsenoside detected in plasma and urine after the oral administration of Rb1.
 <xref rid="med21743-bib-0622" ref-type="ref">
  <sup>622</sup>
 </xref> Deglycosylated products are better absorbed than ginsenosides based on their greater ability to permeate biological membranes.
 <xref rid="med21743-bib-0623" ref-type="ref">
  <sup>623</sup>
 </xref>
</p>
